"With the United States funding 70 percent of the world's research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report [.pdf] released at the International AIDS Society [IAS] conference in Kuala Lumpur this week," the Center for Global Health Policy's "Science Speaks" blog reports. "'From Research to Reality, Investing in HIV Prevention Research in a Challenging Landscape' examines investments, outcomes and next steps in HIV vaccine and microbicide research, antiretroviral treatment as prevention, pre-exposure prophylactic use of antiretroviral drugs, medical circumcision, as well as other biomedical prevention approaches," the blog notes, and details some of the report's findings. "The report, which includes graphics illustrating not only current funding sources, but research involvement through trial participation, concludes the potential of more productive partnerships exists," the blog states (Barton, 7/2).
Back to other news for July 2013
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy